Clinical proteomics: Translating benchside promise into bedside reality

被引:392
|
作者
Petricoin, EF [1 ]
Zoon, KC
Kohn, EC
Barrett, JC
Liotta, LA
机构
[1] US FDA, FDA NCI Clin Proteom Program, Div Therapeut Prot, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
[2] US FDA, Off Director, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
[3] NCI, Ctr Canc Res, NIH, FDA NCI Clin Proteom Program,Lab Pathol, Bethesda, MD 20892 USA
关键词
D O I
10.1038/nrd891
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The ultimate goal of proteomics is to characterize the information flow through protein networks. This information can be a cause, or a consequence, of disease processes. Clinical proteomics is an exciting new subdiscipline of proteomics that involves the application of proteomic technologies at the bedside, and cancer, in particular, is a model disease for studying such applications. Here, we describe proteomic technologies that are being developed to detect cancer earlier, to discover the next generation of targets and imaging biomarkers, and finally to tailor the therapy to the patient.
引用
收藏
页码:683 / 695
页数:13
相关论文
共 50 条
  • [21] Promise of a Novel Bedside-to-Bench Paradigm: Can Percutaneous Coronary Intervention Proteomics Balloon Into Clinical Practice?
    Decano, Julius L.
    Aikawa, Masanori
    Singh, Sasha A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42 (07) : 865 - 867
  • [22] Kinases inhibitors in lung cancer: From benchside to bedside
    Singh, Pankaj Kumar
    Singh, Harpreet
    Silakari, Om
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2016, 1866 (01): : 128 - 140
  • [23] Translating clinical proteomics: the importance of study design
    Maes, Evelyne
    Cho, William C.
    Baggerman, Geert
    EXPERT REVIEW OF PROTEOMICS, 2015, 12 (03) : 217 - 219
  • [24] Translating in vivo diagnostics into clinical reality
    John V Frangioni
    Nature Biotechnology, 2006, 24 : 909 - 913
  • [25] Gene regulation mediated by competing RNA: From benchside to bedside
    Luo, Yumei
    Zhu, Detu
    Fang, Jian-Hong
    FRONTIERS IN GENETICS, 2022, 13
  • [26] The Promise of Palliative Care Translating Clinical Trials to Clinical Care
    Malani, Preeti N.
    Widera, Eric
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (20): : 2090 - 2091
  • [27] Translating in vivo diagnostics into clinical reality
    Frangioni, John V.
    NATURE BIOTECHNOLOGY, 2006, 24 (08) : 909 - 913
  • [28] ESR1 Mutations: From Benchside to Bedside
    Massard, V.
    Harle, A.
    Uwer, L.
    Merlin, J. -L.
    ONCOLOGIE, 2019, 21 (1-4) : 29 - 32
  • [29] Clinical proteomics -: on the long way from bench to bedside?
    Mueller, Gerhard A.
    Mueller, Claudia A.
    Dihazi, Hassan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (05) : 1297 - 1300
  • [30] The promise of proteomics
    Nature, 1999, 402 : 703 - 703